Q1 EPS Estimates for Arcus Biosciences Lifted by Wedbush
Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) – Equities researchers at Wedbush raised their Q1 2025 earnings estimates for Arcus Biosciences in a research note issued on Tuesday, February 25th. Wedbush analyst R. Driscoll now expects that the company will post earnings per share of ($1.08) for the quarter, up from their prior forecast of […]
